Sacroiliac Joint Fusion Market Will Grow At A CAGR of 20.2% by 2032 | Fact.MR Analysis

Fact.MR’s latest report on the Sacroiliac joint fusion market offers a 10-year forecast through 2022 & beyond. The report explicates vital dynamics, such as drivers, restraints, and emerging opportunities shaping the market dynamics.

Rockville, April 17, 2023 (GLOBE NEWSWIRE) — The global sacroiliac joint fusion market is expected to be worth US$ 620 million in 2022 and US$ 3,900 million by 2032. During the projected period of 2022 to 2032, the market is expected to grow at a CAGR of 20.2%.

The market’s expansion can be linked to the healthcare sector’s rapid technological development and the increased need for minimally invasive surgical procedures.

Sacroiliac joint fusion is one of the newest and best procedures to provide relief for sacroiliac pain, and it is routinely performed by orthopedic surgeons at Yale Medicine.

Sacroiliac joint fusion (SIJF) has grown rapidly in popularity in association with the advent of minimally-invasive surgical techniques. This has led to an explosion of new medical devices used for SIJF. The increasing cases of road accidents resulting in joint displacement are touted to kindle the demand for MIS sacroiliac joint fusion treatment. The sacroiliac joint has been reflected as a source of chronic low back pain in nearly 15 to 30% of patients.

Get Free Sample Report to Grow Your Profit Margin –

According to Fact.MR, North America will account for 42% of sales in 2022 and beyond. The region’s high share is due to the presence of key companies, modern healthcare infrastructure, and expanding reimbursement coverage. Also, a surge in joint pain is broadening growth potential.

According to the National Center for Biotechnology Information, the annual prevalence of low back pain among individuals in the United States ranges from 15% to 45%. Significant efforts have been made to better understand the many aetiologies of back pain in response to this disease load and in the hope of improving results. The SI joint, in particular, has recently received increased attention as a pain generator, with estimates of low back pain related to the SI joint ranging from 15% to 30%.

Key Takeaways:

  • By 2022, sacroiliac joint fusion market to be valued at US$ 620 Mn
  • Around 42% of global sacroiliac joint fusion market revenue to be contributed by North America
  • Asia Pacific to experience lucrative growth, registering a 17% value CAGR until 2032
  • By indication, degenerative sacroiliitis to accumulate 39% revenue share in 2022
  • Sacroiliac joint fusion surgeries to account for 40% revenue in 2022 and beyond
  • More than half of all sacroiliac joint fusion procedures to occur across hospitals

Growth Drivers

  • The increasing adoption of minimally invasive surgeries is anticipated to be the key factor driving the market during the forecast period. Further, the improving diagnostic capabilities for sacroiliac joint disorders and the adoption of new technologies are likely to offer better SI joint fusion systems.
  • In addition, the increasing geriatric population in developed countries like the US and the growing incidences of chronic diseases are anticipated to make a significant contribution in boosting the market. As per the 2019 data of the U.S Census Bureau, out of 328 million U.S population, about 75 million were 60 years and above.

Key Restraints:

  • Lack of awareness in the emerging regions and the high cost of the method is projected to restrain the sacroiliac fusion implants market throughout the forecast period.

Get Customization on this Report for Specific Research Solutions

Report AttributesDetails
Estimated Base Year Market Value (2021)US$ 540 Mn
Anticipated Market Value in 2022US$ 620 Mn
Expected Forecast Market Value in 2032US$ 3,900 Mn
Global Growth Rate (2022-2032)20.2% CAGR
Market Share of North America42% 
No of Pages170 Pages
No. of Tables72 Tables
No. of Figures148 Figures

Competitive Landscape:

The various leading players in the Sacroiliac joint fusion market focus on offering various marketing strategies adopted by key players such as mergers and acquisitions, expansions, collaborations, and partnerships.

  • In September 2021, PainTEQ was granted 3 patents in the U.S. for its drill-less method of stabilizing an SI joint, abrading device used in the procedure, and allograft implant respectively. All three offerings are used in the company’s minimally invasive LinQ procedure for SI joint dysfunction, thus solidifying PainTEQ’s position in the market.
  • In June 2020, Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D-printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction.

Key Companies Profiled by Fact.MR

  • SI-BONE Inc.
  • PainTEQ
  • CornerLoc
  • SIGNUS Medizintechnik GmbH
  • Globus Medical
  • Orthofix Medical Inc.
  • Life Spine Inc.
  • Camber Spine Technologies LLC
  • CoreLink Surgical
  • Xtant Medical
  • Surgalign Spine Technologies Inc.
  • Medtronic Plc.

Explore Our Safe & Secure Payment Options for Quick Buy –

Key Segments Covered in the Sacroiliac Joint Fusion Market Report

  • By Indication :
    • Joint Fusion for Degenerative Sacroiliitis
    • Joint Fusion for Sacral Disruption
    • Sacroiliac Joint Fusion for Trauma
  • By Treatment Type :
    • Sacroiliac Joint Fusion Surgery
      • Surgery Type
        • Minimally Invasive Sacroiliac Joint Fusion Surgery
        • Open Sacroiliac Joint Fusion Surgery
      • Approach
        • Dorsal Sacroiliac Joint Fusion
        • Anterior Sacroiliac Joint Fusion
      • Product
        • Sacroiliac Joint Fusion Implants
        • Sacroiliac Joint Fusion Accessories
    • Sacroiliac Joint Fusion Injections
      • Diagnosis
      • Treatment
    • RF Sacroiliac Joint Fusion Ablation
  • By End User :
    • Sacroiliac Joint Fusion in Hospitals
    • Sacroiliac Joint Fusion in Ambulatory Surgical Centers
    • Sacroiliac Joint Fusion for Other End Users (Specialty Centers and Research & Academic Institutes)

Check out more related studies published by Fact.MR Research: 

Joint Reconstruction Devices MarketWorldwide demand for joint reconstruction devices is expected to increase at a CAGR of 6% from 2023 to 2033. The market for joint reconstruction devices is valued at US$ 32.75 billion in 2023 and is thus expected to reach US$ 58.65 billion by the end of 2033. Joint reconstruction devices are used for knee replacement, hip replacement, trauma & extremities, ankle replacement, and others.

Anti-snoring Devices and Snoring Surgery MarketIn FY 2021, the anti-snoring devices and snoring surgery market reached a valuation of US$ 21.32 Billion, and is likely to register a Y-o-Y growth rate of 6.0% in 2022, closing at US$ 22.92 Billion. Furthermore, across the 2022-2032 period of assessment, growth is expected to accelerate at a whopping 7.5% CAGR, reaching US$ 47.23 Billion.

Breast Surgery Retractors MarketThe risk of breast cancer is directly proportional to age. Breast Cancer is the most prevalent invasive cancer among women, affecting those over 40 years of age. It is estimated that over 12% of women develop invasive breast cancer over the course of their lives. A large female geriatric population, combined with rising awareness about breast cancer and early prognosis, is anticipated to leverage the demand for breast retractors.

Image Guided Surgery Devices Market: As per detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, the devices segment, categorized under product, dominated the global image guided surgery devices market in 2021 in terms of revenue and market share, accounting for 75.3% of the total market, and is expected to surge ahead at a CAGR of 8.2% over the forecast period (2022-2032).

Minimally Invasive Surgery MarketThe global minimally invasive surgery market is likely to be valued at US$ 6.31 Billion in FY 2022, up from US$ 6 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 5.2%. From 2022 to 2032, the market is poised to flourish at a CAGR of 5.2% to reach a value of US$ 10.5 Billion.

About Us:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Connect to Author: Shambhu Nath Jha
Sales Team :
Follow Us: LinkedIn | Twitter | YouTube

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button